Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Common <i>CD36</i> Variant and the Genetic Landscape of Dilated Cardiomyopathy in Individuals of African Ancestry.

medRxiv : the preprint server for health sciences·2026

Same author

Care Models for the Genetic Evaluation of Dilated Cardiomyopathy at Sites of the DCM Consortium.

medRxiv : the preprint server for health sciences·2026

Same author

Evaluation of Women With Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.

Circulation. Genomic and precision medicine·2026

Same author

Exon Utilization Improves Risk Stratification for Advanced Heart Failure in Titin Cardiomyopathy.

medRxiv : the preprint server for health sciences·2025

Same author

Systemic barriers and opportunities for equity in early implementation of genetic testing and counseling for cardiomyopathies in Tanzania.

Communications medicine·2025

Same author

Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial.

Journal of the American College of Cardiology·2025

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Ray E Hershberger¹

¹Cardiovascular Division, Clinical Research Building, Miller School of Medicine, University of Miami, Miami, FL 33101, USA. rhershberger@med.miami.edu

Journal of Cardiovascular Translational Research

|June 19, 2010

Summary

Cardiovascular genetic medicine identifies and treats inherited heart conditions. Early genetic risk assessment and intervention can prevent serious cardiac events and improve patient outcomes.

More Related Videos

An Efficient Transgenesis Approach for Gene Delivery in the Mouse Embryonic Heart

An Efficient Transgenesis Approach for Gene Delivery in the Mouse Embryonic Heart

Published on: May 24, 2024

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

Related Experiment Videos

Last Updated: Jun 12, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

An Efficient Transgenesis Approach for Gene Delivery in the Mouse Embryonic Heart

An Efficient Transgenesis Approach for Gene Delivery in the Mouse Embryonic Heart

Published on: May 24, 2024

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

Area of Science:

Cardiovascular Medicine
Genetics
Genomics

Background:

Cardiovascular genetic medicine focuses on inherited cardiac conditions.
Clinics offer specialized care, genetic counseling, and testing.
Single-gene disorders like cardiomyopathies and channelopathies are primary targets.

Purpose of the Study:

To outline the scope and impact of cardiovascular genetic medicine.
To highlight the benefits of genetic testing for inherited cardiac diseases.
To emphasize the potential for preventing cardiovascular morbidity and mortality.

Main Methods:

Identification and understanding of genetic and genomic mechanisms in cardiac conditions.
Development and validation of diagnostic and treatment algorithms.
Clinical genetic testing and counseling for cardiovascular diseases.

Main Results:

Advances in genetic knowledge have accelerated testing and benefits.
Presymptomatic genetic risk identification offers preventive potential.
Cardiovascular genetic medicine programs support training and research.

Conclusions:

Cardiovascular genetic medicine is crucial for managing inherited heart diseases.
Genetic testing and early intervention can significantly reduce adverse cardiovascular events.
These programs are vital for advancing research and training future specialists.